| Requirement of bic/microRNA-155 for normal immune function A Rodriguez, E Vigorito, S Clare, MV Warren, P Couttet, DR Soond, ... Science 316 (5824), 608, 2007 | 2354 | 2007 |
| Cellular function of phosphoinositide 3-kinases: implications for development, immunity, homeostasis, and cancer R Katso, K Okkenhaug, K Ahmadi, S White, J Timms, MD Waterfield Annual review of cell and developmental biology 17 (1), 615-675, 2001 | 1663 | 2001 |
| Ribosomal protein S6 kinase 1 signaling regulates mammalian life span C Selman, J Tullet, D Wieser, E Irvine, SJ Lingard, AI Choudhury, M Claret, ... Science 326 (5949), 140, 2009 | 1238 | 2009 |
| Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice K Okkenhaug, A Bilancio, G Farjot, H Priddle, S Sancho, E Peskett, ... Science 297 (5583), 1031, 2002 | 1167 | 2002 |
| PI3K in lymphocyte development, differentiation and activation K Okkenhaug, B Vanhaesebroeck Nature Reviews Immunology 3 (4), 317-330, 2003 | 983 | 2003 |
| Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage I Angulo, O Vadas, F Garçon, E Banham-Hall, V Plagnol, TR Leahy, ... Science 342 (6169), 866-871, 2013 | 625 | 2013 |
| PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells DK Finlay, E Rosenzweig, LV Sinclair, C Feijoo-Carnero, JL Hukelmann, ... The Journal of Experimental Medicine 209 (13), 2441-2453, 2012 | 623 | 2012 |
| Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice C Selman, S Lingard, AI Choudhury, RL Batterham, M Claret, M Clements, ... The FASEB Journal 22 (3), 807-818, 2008 | 607 | 2008 |
| Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study TI Coulter, A Chandra, CM Bacon, J Babar, J Curtis, N Screaton, ... Journal of Allergy and Clinical Immunology 139 (2), 597-606. e4, 2017 | 596 | 2017 |
| Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation LC Foukas, M Claret, W Pearce, K Okkenhaug, S Meek, E Peskett, ... Nature 441 (7091), 366-370, 2006 | 564 | 2006 |
| Ionic immune suppression within the tumour microenvironment limits T cell effector function R Eil, SK Vodnala, D Clever, CA Klebanoff, M Sukumar, JH Pan, ... Nature 537 (7621), 539-543, 2016 | 538 | 2016 |
| Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer K Ali, DR Soond, R Piñeiro, T Hagemann, W Pearce, EL Lim, H Bouabe, ... Nature 510 (7505), 407-411, 2014 | 535 | 2014 |
| Essential role for the p110δ phosphoinositide 3-kinase in the allergic response K Ali, A Bilancio, M Thomas, W Pearce, AM Gilfillan, C Tkaczyk, N Kuehn, ... Nature 431 (7011), 1007-1011, 2004 | 506 | 2004 |
| Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells K Okkenhaug Annual review of immunology 31 (1), 2013 | 471 | 2013 |
| Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells S Kohlhaas, OA Garden, C Scudamore, M Turner, K Okkenhaug, ... The Journal of Immunology 182 (5), 2578-2582, 2009 | 469 | 2009 |
| Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking LV Sinclair, D Finlay, C Feijoo, GH Cornish, A Gray, A Ager, K Okkenhaug, ... Nature immunology 9 (5), 513-521, 2008 | 448 | 2008 |
| The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ J Guillermet-Guibert, K Bjorklof, A Salpekar, C Gonella, F Ramadani, ... Proceedings of the National Academy of Sciences 105 (24), 8292-8297, 2008 | 439 | 2008 |
| Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils AM Condliffe, K Davidson, KE Anderson, CD Ellson, T Crabbe, ... Blood 106 (4), 1432-1440, 2005 | 384 | 2005 |
| Cutting edge: the phosphoinositide 3-kinase p110δ is critical for the function of CD4+ CD25+ Foxp3+ regulatory T cells DT Patton, OA Garden, WP Pearce, LE Clough, CR Monk, E Leung, ... The Journal of Immunology 177 (10), 6598-6602, 2006 | 367 | 2006 |
| PI3K inhibitors in inflammation, autoimmunity and cancer AK Stark, S Sriskantharajah, EM Hessel, K Okkenhaug Current opinion in pharmacology 23, 82-91, 2015 | 315 | 2015 |
Bart VanhaesebroeckUCL Cancer Institute, University College London, London UKVerified email at ucl.ac.uk
